ABBV vs TNC · P/E 81, rev $61.16B vs P/E 51, rev $1.29B
AbbVie Inc (ABBV) versus Tennant Company (TNC) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Tennant Company (TNC) is a specialty industrial machinery company listed on NYSE.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported TNC revenue for 2024-12-31 was $1.29B. Net income was $83.7M. Revenue was up 3.5% from 2023-12-31 to 2024-12-31. TNC currently screens at market cap $1.46B and trailing P/E 51.1.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. TNC currently screens at market cap $1.46B and trailing P/E 51.1.
Not investment advice. Open the ABBV and TNC stock pages for the full models.
Not investment advice.